Health Boards
Manchester is today celebrating success after securing £12.5million of Government funding for clinical research.
Three leading hospital trusts, working closely with the University of Manchester, have been awarded the money to carry out research into many of the major diseases and illnesses that affect the population of Greater Manchester and the wider North West.
The three Clinical Research Facilities that will receive funding are:
#1 Central Manchester University Hospitals NHS Foundation Trust who will use the £5.5 million funding to support studies for people with diseases such as arthritis, psoriasis, depression, addiction, and diabetes.
#2 The Christie NHS Foundation Trust who will use the £4.5million funding to support early-stage trials of treatments for people with cancer.
#3 University Hospital of South Manchester NHS Foundation Trust who will use the £2.5million funding to support early-stage trials of treatments for people with lung diseases such as asthma, fungal infection, chronic obstructive pulmonary disease, and also food allergies.
Researchers believe the success of these bids reflects the scale of expertise in conducting clinical trials in NHS organisations in Manchester and the University of Manchester which collectively form MAHSC (Manchester Academic Health Science Centre).
Professor Ian Jacobs is Director of MAHSC and Vice President of the University of Manchester. He believes this is a Red Letter Day for Manchester and further enhances the reputation of the city as a leading international centre for healthcare and health science.
He explains: “An extraordinary level of collaborative joint working has been achieved which makes it possible to conduct trials of the highest quality, on a large scale in a broad range of health areas including cancer, respiratory, neurological, cardiovascular, musculoskeletal and inflammatory disorders. This funding will lead to new healthcare innovations which will be rapidly applied for the benefit of our population through the MAHSC partnership.”
NHS Trusts and Foundation Trusts with clinical research facilities submitted bids for the funding, which were judged by a panel of UK experts in both medical research and in running clinical research facilities. Winning bids were selected on the basis of the quality and volume of world-class medical research they support as well as other criteria including the strength of their partnerships with universities and industry
Secretary of State for Health, Andrew Lansley says: “Both public and patients think it’s important that the NHS should support research into new treatments, and we agree. That’s why we’re investing over £100m in research facilities, nurses and technicians to help make the NHS a world-class place to do research.
Source: mahsc.ac.uk
Three leading hospital trusts, working closely with the University of Manchester, have been awarded the money to carry out research into many of the major diseases and illnesses that affect the population of Greater Manchester and the wider North West.
The three Clinical Research Facilities that will receive funding are:
#1 Central Manchester University Hospitals NHS Foundation Trust who will use the £5.5 million funding to support studies for people with diseases such as arthritis, psoriasis, depression, addiction, and diabetes.
#2 The Christie NHS Foundation Trust who will use the £4.5million funding to support early-stage trials of treatments for people with cancer.
#3 University Hospital of South Manchester NHS Foundation Trust who will use the £2.5million funding to support early-stage trials of treatments for people with lung diseases such as asthma, fungal infection, chronic obstructive pulmonary disease, and also food allergies.
Researchers believe the success of these bids reflects the scale of expertise in conducting clinical trials in NHS organisations in Manchester and the University of Manchester which collectively form MAHSC (Manchester Academic Health Science Centre).
Professor Ian Jacobs is Director of MAHSC and Vice President of the University of Manchester. He believes this is a Red Letter Day for Manchester and further enhances the reputation of the city as a leading international centre for healthcare and health science.
He explains: “An extraordinary level of collaborative joint working has been achieved which makes it possible to conduct trials of the highest quality, on a large scale in a broad range of health areas including cancer, respiratory, neurological, cardiovascular, musculoskeletal and inflammatory disorders. This funding will lead to new healthcare innovations which will be rapidly applied for the benefit of our population through the MAHSC partnership.”
NHS Trusts and Foundation Trusts with clinical research facilities submitted bids for the funding, which were judged by a panel of UK experts in both medical research and in running clinical research facilities. Winning bids were selected on the basis of the quality and volume of world-class medical research they support as well as other criteria including the strength of their partnerships with universities and industry
Secretary of State for Health, Andrew Lansley says: “Both public and patients think it’s important that the NHS should support research into new treatments, and we agree. That’s why we’re investing over £100m in research facilities, nurses and technicians to help make the NHS a world-class place to do research.
Source: mahsc.ac.uk